Unknown

Dataset Information

0

Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions.


ABSTRACT: Treatment of choice for nodular basal-cell carcinomas (BCCs) is complete excision, implying that small lesions are of minor concern. Metastasis is very rare (

SUBMITTER: Niebel D 

PROVIDER: S-EPMC7367955 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical Management of Locally Advanced Basal-Cell Carcinomas and Future Therapeutic Directions.

Niebel Dennis D   Sirokay Judith J   Hoffmann Friederike F   Fröhlich Anne A   Bieber Thomas T   Landsberg Jennifer J  

Dermatology and therapy 20200507 4


Treatment of choice for nodular basal-cell carcinomas (BCCs) is complete excision, implying that small lesions are of minor concern. Metastasis is very rare (< 1%). However, locally advanced basal-cell carcinomas (laBCCs), which are ineligible for surgery or radiation, are a therapeutic challenge. First-generation Smoothened (SMO) inhibitors (vismodegib, sonidegib) have been approved for treatment, but common side effects limit their use. Numerous new compounds are being investigated in clinical  ...[more]

Similar Datasets

| S-EPMC4066644 | biostudies-literature
| S-EPMC4339053 | biostudies-literature
| S-EPMC4807161 | biostudies-literature
| S-EPMC7672503 | biostudies-literature
| S-EPMC3423575 | biostudies-literature
| S-EPMC6746032 | biostudies-literature
| S-EPMC7072318 | biostudies-literature
| S-EPMC8765439 | biostudies-literature
| S-EPMC8000187 | biostudies-literature